These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33581254)

  • 1. Deletion of the Na-K-2Cl cotransporter NKCC1 results in a more severe epileptic phenotype in the intrahippocampal kainate mouse model of temporal lobe epilepsy.
    Hampel P; Johne M; Gailus B; Vogel A; Schidlitzki A; Gericke B; Töllner K; Theilmann W; Käufer C; Römermann K; Kaila K; Löscher W
    Neurobiol Dis; 2021 May; 152():105297. PubMed ID: 33581254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A face-to-face comparison of the intra-amygdala and intrahippocampal kainate mouse models of mesial temporal lobe epilepsy and their utility for testing novel therapies.
    Welzel L; Schidlitzki A; Twele F; Anjum M; Löscher W
    Epilepsia; 2020 Jan; 61(1):157-170. PubMed ID: 31828786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease-modifying effects of phenobarbital and the NKCC1 inhibitor bumetanide in the pilocarpine model of temporal lobe epilepsy.
    Brandt C; Nozadze M; Heuchert N; Rattka M; Löscher W
    J Neurosci; 2010 Jun; 30(25):8602-12. PubMed ID: 20573906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Various modifications of the intrahippocampal kainate model of mesial temporal lobe epilepsy in rats fail to resolve the marked rat-to-mouse differences in type and frequency of spontaneous seizures in this model.
    Klee R; Brandt C; Töllner K; Löscher W
    Epilepsy Behav; 2017 Mar; 68():129-140. PubMed ID: 28167446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockout of P-glycoprotein does not alter antiepileptic drug efficacy in the intrahippocampal kainate model of mesial temporal lobe epilepsy in mice.
    Bankstahl M; Klein S; Römermann K; Löscher W
    Neuropharmacology; 2016 Oct; 109():183-195. PubMed ID: 27288003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The intrahippocampal kainate model of temporal lobe epilepsy revisited: epileptogenesis, behavioral and cognitive alterations, pharmacological response, and hippoccampal damage in epileptic rats.
    Rattka M; Brandt C; Löscher W
    Epilepsy Res; 2013 Feb; 103(2-3):135-52. PubMed ID: 23196211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the NKCC1 inhibitors bumetanide, azosemide, and torasemide alone or in combination with phenobarbital on seizure threshold in epileptic and nonepileptic mice.
    Hampel P; Römermann K; Gailus B; Johne M; Gericke B; Kaczmarek E; Löscher W
    Neuropharmacology; 2021 Mar; 185():108449. PubMed ID: 33450274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant effects of sex, strain, and anesthesia in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy.
    Twele F; Töllner K; Brandt C; Löscher W
    Epilepsy Behav; 2016 Feb; 55():47-56. PubMed ID: 26736063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of mTORC1/2 or PI3K/mTORC1/2 signaling does not prevent or modify epilepsy in the intrahippocampal kainate mouse model.
    Gericke B; Brandt C; Theilmann W; Welzel L; Schidlitzki A; Twele F; Kaczmarek E; Anjum M; Hillmann P; Löscher W
    Neuropharmacology; 2020 Jan; 162():107817. PubMed ID: 31654704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BDNF modifies hippocampal KCC2 and NKCC1 expression in a temporal lobe epilepsy model.
    Eftekhari S; Mehrabi S; Soleimani M; Hassanzadeh G; Shahrokhi A; Mostafavi H; Hayat P; Barati M; Mehdizadeh H; Rahmanzadeh R; Hadjighassem MR; Joghataei MT
    Acta Neurobiol Exp (Wars); 2014; 74(3):276-87. PubMed ID: 25231847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous recurrent seizures in an intra-amygdala kainate microinjection model of temporal lobe epilepsy are differentially sensitive to antiseizure drugs.
    West PJ; Thomson K; Billingsley P; Pruess T; Rueda C; Saunders GW; Smith MD; Metcalf CS; Wilcox KS
    Exp Neurol; 2022 Mar; 349():113954. PubMed ID: 34922908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated low-dose kainate administration in C57BL/6J mice produces temporal lobe epilepsy pathology but infrequent spontaneous seizures.
    Umpierre AD; Bennett IV; Nebeker LD; Newell TG; Tian BB; Thomson KE; White HS; White JA; Wilcox KS
    Exp Neurol; 2016 May; 279():116-126. PubMed ID: 26896834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The intrahippocampal kainate mouse model of mesial temporal lobe epilepsy: Lack of electrographic seizure-like events in sham controls.
    Twele F; Schidlitzki A; Töllner K; Löscher W
    Epilepsia Open; 2017 Jun; 2(2):180-187. PubMed ID: 29588947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cav3.1 T-type calcium channel modulates the epileptogenicity of hippocampal seizures in the kainic acid-induced temporal lobe epilepsy model.
    Kim CH
    Brain Res; 2015 Oct; 1622():204-16. PubMed ID: 26111648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bumetanide-sensitive Na-K-2Cl cotransporter NKCC1 as a potential target of a novel mechanism-based treatment strategy for neonatal seizures.
    Kahle KT; Staley KJ
    Neurosurg Focus; 2008 Sep; 25(3):E22. PubMed ID: 18759624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1400W, a highly selective inducible nitric oxide synthase inhibitor is a potential disease modifier in the rat kainate model of temporal lobe epilepsy.
    Puttachary S; Sharma S; Verma S; Yang Y; Putra M; Thippeswamy A; Luo D; Thippeswamy T
    Neurobiol Dis; 2016 Sep; 93():184-200. PubMed ID: 27208748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A guinea pig model of mesial temporal lobe epilepsy following nonconvulsive status epilepticus induced by unilateral intrahippocampal injection of kainic acid.
    Carriero G; Arcieri S; Cattalini A; Corsi L; Gnatkovsky V; de Curtis M
    Epilepsia; 2012 Nov; 53(11):1917-27. PubMed ID: 22998690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The AMPA receptor antagonist NBQX exerts anti-seizure but not antiepileptogenic effects in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy.
    Twele F; Bankstahl M; Klein S; Römermann K; Löscher W
    Neuropharmacology; 2015 Aug; 95():234-42. PubMed ID: 25839899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urokinase-type plasminogen activator receptor modulates epileptogenesis in mouse model of temporal lobe epilepsy.
    Ndode-Ekane XE; Pitkänen A
    Mol Neurobiol; 2013 Jun; 47(3):914-37. PubMed ID: 23263886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NKCC1 up-regulation contributes to early post-traumatic seizures and increased post-traumatic seizure susceptibility.
    Wang F; Wang X; Shapiro LA; Cotrina ML; Liu W; Wang EW; Gu S; Wang W; He X; Nedergaard M; Huang JH
    Brain Struct Funct; 2017 Apr; 222(3):1543-1556. PubMed ID: 27586142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.